Literature DB >> 21185416

Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone.

Jeffry S Nyman1, Jesse L Even, Chan-Hee Jo, Erik G Herbert, Matthew R Murry, Gael E Cockrell, Elizabeth C Wahl, R Clay Bunn, Charles K Lumpkin, John L Fowlkes, Kathryn M Thrailkill.   

Abstract

Type 1 diabetes (T1DM) increases the likelihood of a fracture. Despite serious complications in the healing of fractures among those with diabetes, the underlying causes are not delineated for the effect of diabetes on the fracture resistance of bone. Therefore, in a mouse model of T1DM, we have investigated the possibility that a prolonged state of diabetes perturbs the relationship between bone strength and structure (i.e., affects tissue properties). At 10, 15, and 18 weeks following injection of streptozotocin to induce diabetes, diabetic male mice and age-matched controls were examined for measures of skeletal integrity. We assessed 1) the moment of inertia (I(MIN)) of the cortical bone within diaphysis, trabecular bone architecture of the metaphysis, and mineralization density of the tissue (TMD) for each compartment of the femur by micro-computed tomography and 2) biomechanical properties by three-point bending test (femur) and nanoindentation (tibia). In the metaphysis, a significant decrease in trabecular bone volume fraction and trabecular TMD was apparent after 10 weeks of diabetes. For cortical bone, type 1 diabetes was associated with decreased cortical TMD, I(MIN), rigidity, and peak moment as well as a lack of normal age-related increases in the biomechanical properties. However, there were only modest differences in material properties between diabetic and normal mice at both whole bone and tissue-levels. As the duration of diabetes increased, bone toughness decreased relative to control. If the sole effect of diabetes on bone strength was due to a reduction in bone size, then I(MIN) would be the only significant variable explaining the variance in the maximum moment. However, general linear modeling found that the relationship between peak moment and I(MIN) depended on whether the bone was from a diabetic mouse and the duration of diabetes. Thus, these findings suggest that the elevated fracture risk among diabetics is impacted by complex changes in tissue properties that ultimately reduce the fracture resistance of bone. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185416      PMCID: PMC3062641          DOI: 10.1016/j.bone.2010.12.016

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  56 in total

1.  Automatic segmentation of cortical and trabecular compartments based on a dual threshold technique for in vivo micro-CT bone analysis.

Authors:  Helen R Buie; Graeme M Campbell; R Joshua Klinck; Joshua A MacNeil; Steven K Boyd
Journal:  Bone       Date:  2007-07-18       Impact factor: 4.398

2.  Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women.

Authors:  K K Nicodemus; A R Folsom
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

3.  Hierarchical relationship between bone traits and mechanical properties in inbred mice.

Authors:  Karl J Jepsen; Ozan J Akkus; Robert J Majeska; Joseph H Nadeau
Journal:  Mamm Genome       Date:  2003-02       Impact factor: 2.957

4.  The biomechanical integrity of bone in experimental diabetes.

Authors:  G K Reddy; L Stehno-Bittel; S Hamade; C S Enwemeka
Journal:  Diabetes Res Clin Pract       Date:  2001-10       Impact factor: 5.602

Review 5.  Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture.

Authors:  Mohsen Janghorbani; Rob M Van Dam; Walter C Willett; Frank B Hu
Journal:  Am J Epidemiol       Date:  2007-06-16       Impact factor: 4.897

Review 6.  Diabetes mellitus, bone mineral density, and fracture risk.

Authors:  Elsa S Strotmeyer; Jane A Cauley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2007-12       Impact factor: 3.243

7.  Bone size normalizes with age in children and adolescents with type 1 diabetes.

Authors:  Susanne Bechtold; Stefanie Putzker; Walter Bonfig; Oliver Fuchs; Isa Dirlenbach; Hans Peter Schwarz
Journal:  Diabetes Care       Date:  2007-04-24       Impact factor: 19.112

Review 8.  Diabetes, fracture, and bone fragility.

Authors:  Ann V Schwartz; Deborah E Sellmeyer
Journal:  Curr Osteoporos Rep       Date:  2007-09       Impact factor: 5.096

9.  Age-related changes in the collagen network and toughness of bone.

Authors:  X Wang; X Shen; X Li; C Mauli Agrawal
Journal:  Bone       Date:  2002-07       Impact factor: 4.398

10.  Risk-adjusted mortality rates of elderly veterans with hip fractures.

Authors:  Elizabeth Bass; Dustin D French; Douglas D Bradham; Laurence Z Rubenstein
Journal:  Ann Epidemiol       Date:  2007-04-08       Impact factor: 3.797

View more
  51 in total

Review 1.  Type 2 diabetes and bone fractures.

Authors:  Kendall F Moseley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-04       Impact factor: 3.243

2.  The effects of low-level laser irradiation on bone tissue in diabetic rats.

Authors:  Tatiane Lopes Patrocínio-Silva; André Moreira Fogaça de Souza; Raul Loppi Goulart; Carolina Fuirini Pegorari; Jussan Rodrigues Oliveira; Kelly Fernandes; Angela Magri; Rosa Maria Rodrigues Pereira; Daniel Ribeiro Araki; Márcia Regina Nagaoka; Nivaldo Antônio Parizotto; Ana Cláudia Muniz Rennó
Journal:  Lasers Med Sci       Date:  2013-08-29       Impact factor: 3.161

3.  Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes.

Authors:  K M Thrailkill; C-H Jo; G E Cockrell; C S Moreau; C K Lumpkin; J L Fowlkes
Journal:  Osteoporos Int       Date:  2011-11-09       Impact factor: 4.507

Review 4.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

5.  The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes.

Authors:  Kathryn M Thrailkill; Jeffry S Nyman; R Clay Bunn; Sasidhar Uppuganti; Katherine L Thompson; Charles K Lumpkin; Evangelia Kalaitzoglou; John L Fowlkes
Journal:  Bone       Date:  2016-10-28       Impact factor: 4.398

Review 6.  A new perspective on mechanisms governing skeletal complications in type 1 diabetes.

Authors:  Zeynep Seref-Ferlengez; Sylvia O Suadicani; Mia M Thi
Journal:  Ann N Y Acad Sci       Date:  2016-08-29       Impact factor: 5.691

Review 7.  Bone-Targeting Systems to Systemically Deliver Therapeutics to Bone Fractures for Accelerated Healing.

Authors:  Jeffery J Nielsen; Stewart A Low
Journal:  Curr Osteoporos Rep       Date:  2020-10       Impact factor: 5.096

8.  Contributions of the Insulin/Insulin-Like Growth Factor-1 Axis to Diabetic Osteopathy.

Authors:  John L Fowlkes; Clay Bunn R; Kathryn M Thrailkill
Journal:  J Diabetes Metab       Date:  2011-11-25

Review 9.  Diabetes and Its Effect on Bone and Fracture Healing.

Authors:  Hongli Jiao; E Xiao; Dana T Graves
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

10.  SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice.

Authors:  Kathryn M Thrailkill; R Clay Bunn; Jeffry S Nyman; Mallikarjuna R Rettiganti; Gael E Cockrell; Elizabeth C Wahl; Sasidhar Uppuganti; Charles K Lumpkin; John L Fowlkes
Journal:  Bone       Date:  2015-07-23       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.